{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:59:29Z","timestamp":1780779569683,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.neurot.2026.e00905","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:49:59Z","timestamp":1775911799000},"page":"e00905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA-binding protein MBNL2 mitigates neuropathic pain after chemotherapy through destabilizing CCR2 expression in primary sensory neurons"],"prefix":"10.1016","volume":"23","author":[{"given":"Keshi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruining","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice S.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Xiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.neurot.2026.e00905_bib1","doi-asserted-by":"crossref","first-page":"iv45","DOI":"10.1093\/neuonc\/nos203","article-title":"Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention","volume":"14","author":"Grisold","year":"2012","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy","volume":"13","author":"Windebank","year":"2008","journal-title":"J Peripher Nerv Syst"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): an update","volume":"82","author":"Argyriou","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Suppl 6","key":"10.1016\/j.neurot.2026.e00905_bib4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0304-3959(99)00135-9","article-title":"Unexplained peculiarities of the dorsal root ganglion","author":"Devor","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neurot.2026.e00905_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8069-4-10","article-title":"Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: implications for chemical-induced peripheral sensory neuropathies","volume":"4","author":"Jimenez-Andrade","year":"2008","journal-title":"Mol Pain"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00905_bib6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1523\/JNEUROSCI.0899-17.2017","article-title":"DRG voltage-gated sodium channel 1.7 is upregulated in paclitaxel-induced neuropathy in rats and in humans with neuropathic pain","volume":"38","author":"Li","year":"2018","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00905_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/j.pain.0000000000000774","article-title":"Dorsal root ganglion neurons become hyperexcitable and increase expression of voltage-gated T-type calcium channels (Cav3.2) in paclitaxel-induced peripheral neuropathy","volume":"158","author":"Li","year":"2017","journal-title":"Pain"},{"issue":"44","key":"10.1016\/j.neurot.2026.e00905_bib8","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1073\/pnas.1613246113","article-title":"Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain","volume":"113","author":"Sisignano","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00905_bib9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/ALN.0000000000000176","article-title":"Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy","volume":"120","author":"Zhang","year":"2014","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.112.202192","article-title":"Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain","volume":"345","author":"Cai","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2010.03.044","article-title":"The excitatory effects of the chemokine CCL2 on DRG somata are greater after an injury of the ganglion than after an injury of the spinal or peripheral nerve","volume":"475","author":"Wang","year":"2010","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00905_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mi.9.4.7","article-title":"Chemokine signaling and the management of neuropathic pain","volume":"9","author":"White","year":"2009","journal-title":"Mol Interv"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00905_bib13","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/j.pain.0000000000001212","article-title":"Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity","volume":"159","author":"Illias","year":"2018","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00905_bib14","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jpain.2013.03.012","article-title":"Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy","volume":"14","author":"Zhang","year":"2013","journal-title":"J Pain"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1471-4159.2007.04969.x","article-title":"Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons","volume":"104","author":"Jung","year":"2008","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00905_bib16","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1152\/jn.00222.2006","article-title":"MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia","volume":"96","author":"Sun","year":"2006","journal-title":"J Neurophysiol"},{"issue":"15","key":"10.1016\/j.neurot.2026.e00905_bib17","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1523\/JNEUROSCI.5986-10.2011","article-title":"CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury","volume":"31","author":"Van","year":"2011","journal-title":"J Neurosci"},{"issue":"39","key":"10.1016\/j.neurot.2026.e00905_bib18","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.0503496102","article-title":"Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion","volume":"102","author":"White","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"50","key":"10.1016\/j.neurot.2026.e00905_bib19","doi-asserted-by":"crossref","first-page":"18381","DOI":"10.1523\/JNEUROSCI.3386-11.2011","article-title":"The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a gbetagamma-dependent mechanism","volume":"31","author":"Belkouch","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2026.e00905_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1742-2094-9-189","article-title":"CC chemokine ligand 2 upregulates the current density and expression of TRPV1 channels and Nav1.8 sodium channels in dorsal root ganglion neurons","volume":"9","author":"Kao","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00905_bib21","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20140005","article-title":"PKC-NF-kappaB are involved in CCL2-induced Nav1.8 expression and channel function in dorsal root ganglion neurons","volume":"34","author":"Zhao","year":"2014","journal-title":"Biosci Rep"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00905_bib22","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.1331358100","article-title":"Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2","volume":"100","author":"Abbadie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00905_bib23","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1523\/JNEUROSCI.3623-08.2009","article-title":"JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain","volume":"29","author":"Gao","year":"2009","journal-title":"J Neurosci"},{"issue":"Pt 3","key":"10.1016\/j.neurot.2026.e00905_bib24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/brain\/aws330","article-title":"Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain","volume":"136","author":"Imai","year":"2013","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.neurot.2026.e00905_bib25","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1523\/JNEUROSCI.5986-10.2011","article-title":"CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury","volume":"31","author":"Van Steenwinckel","year":"2011","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00905_bib26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ejp.1169","article-title":"Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy-induced neuropathy","volume":"22","author":"Al-Mazidi","year":"2018","journal-title":"Eur J Pain"},{"issue":"2-3","key":"10.1016\/j.neurot.2026.e00905_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1432-0436.2006.00060.x","article-title":"The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing","volume":"74","author":"Pascual","year":"2006","journal-title":"Differentiation"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00905_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1567-133X(03)00064-4","article-title":"Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3","volume":"3","author":"Kanadia","year":"2003","journal-title":"Gene Expr Patterns"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2353\/ajpath.2009.080520","article-title":"Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle","volume":"174","author":"Holt","year":"2009","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00905_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cell.2012.06.041","article-title":"Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins","volume":"150","author":"Wang","year":"2012","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00905_bib31","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.biocel.2013.08.008","article-title":"RNA binding proteins in the regulation of heart development","volume":"45","author":"Blech-Hermoni","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"17","key":"10.1016\/j.neurot.2026.e00905_bib32","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1093\/nar\/gku767","article-title":"MBNL proteins and their target RNAs, interaction and splicing regulation","volume":"42","author":"Konieczny","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00905_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/dvdy.21428","article-title":"Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy","volume":"237","author":"Hao","year":"2008","journal-title":"Dev Dyn"},{"issue":"5652","key":"10.1016\/j.neurot.2026.e00905_bib34","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1126\/science.1088583","article-title":"A muscleblind knockout model for myotonic dystrophy","volume":"302","author":"Kanadia","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neurot.2026.e00905_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120486","article-title":"TET1 overexpression attenuates paclitaxel-induced neuropathic pain through rescuing K2p1.1 expression in primary sensory neurons of male rats","volume":"297","author":"Jia","year":"2022","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00905_bib36","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/ijc.32155","article-title":"DNMT3a-triggered downregulation of K2p 1.1 gene in primary sensory neurons contributes to paclitaxel-induced neuropathic pain","volume":"145","author":"Mao","year":"2019","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00905_bib37","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s13311-021-01158-8","article-title":"A compound mitigates cancer pain and chemotherapy-induced neuropathic pain by dually targeting nNOS-PSD-95 interaction and GABAA receptor","volume":"18","author":"Wei","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00905_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bja.2022.09.027","article-title":"Effect of intrathecal NIS-lncRNA antisense oligonucleotides on neuropathic pain caused by nerve trauma, chemotherapy, or diabetes mellitus","volume":"130","author":"Wen","year":"2023","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s13311-020-00931-5","article-title":"CREB participates in paclitaxel-induced neuropathic pain genesis through transcriptional activation of Dnmt3a in primary sensory neurons","volume":"18","author":"Yang","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00905_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153563","article-title":"A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression","volume":"132","author":"Du","year":"2022","journal-title":"J Clin Investig"},{"issue":"13","key":"10.1016\/j.neurot.2026.e00905_bib41","article-title":"Downregulation of a dorsal root ganglion-specifically enriched long noncoding RNA is required for neuropathic pain by negatively regulating RALY-triggered Ehmt2 expression","volume":"8","author":"Pan","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00905_bib42","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1093\/brain\/awad110","article-title":"A sensory neuron-specific long non-coding RNA reduces neuropathic pain by rescuing KCNN1 expression","volume":"146","author":"Wang","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e00905_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14712","article-title":"DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00905_bib44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nn.3438","article-title":"A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons","volume":"16","author":"Zhao","year":"2013","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00905_bib45","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bja.2024.07.024","article-title":"RNA-binding protein SYNCRIP contributes to neuropathic pain through stabilising CCR2 expression in primary sensory neurones","volume":"133","author":"Zhang","year":"2024","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00905_bib46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bph.16259","article-title":"RALY participates in nerve trauma-induced nociceptive hypersensitivity through triggering Eif4g2 gene expression in primary sensory neurons","volume":"181","author":"Huang","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00905_bib47","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1523\/JNEUROSCI.2082-22.2022","article-title":"FUS contributes to nerve injury-induced nociceptive hypersensitivity by activating NF-kappaB pathway in primary sensory neurons","volume":"43","author":"Han","year":"2023","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00905_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/104303403765701187","article-title":"Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors","volume":"14","author":"Xu","year":"2003","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00905_bib49","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1073\/pnas.0930324100","article-title":"Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception","volume":"100","author":"Xu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2026.e00905_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/srep00209","article-title":"CUGBP1 and MBNL1 preferentially bind to 3' UTRs and facilitate mRNA decay","volume":"2","author":"Masuda","year":"2012","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00905_bib51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molcel.2014.08.027","article-title":"Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease","volume":"56","author":"Batra","year":"2014","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12964-025-02102-5","article-title":"Functions of the Muscleblind-like protein family and their role in disease","volume":"23","author":"Zhou","year":"2025","journal-title":"Cell Commun Signal"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00905_bib53","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.ymthe.2025.04.045","article-title":"Current clinical applications of AAV-mediated gene therapy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.70106","article-title":"Viral vector-based gene therapies in the clinic: an update","volume":"11","author":"Park","year":"2026","journal-title":"Bioeng Transl Med"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00905_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ph17091213","article-title":"Gene therapy in the light of lifestyle diseases: budesonide, Acetaminophen and Simvastatin modulates rAAV transduction efficiency","volume":"17","author":"Slyk","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00905_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T20:26:49Z","timestamp":1780777609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1878747926000759"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00905","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA-binding protein MBNL2 mitigates neuropathic pain after chemotherapy through destabilizing CCR2 expression in primary sensory neurons","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00905"}}